Functional genomic and serological analysis of the protective immune response resulting from vaccination of macaques with an NS1-truncated influenza virus.
We are still inadequately prepared for an influenza pandemic due to the lack of a vaccine effective for subtypes to which the majority of the human population has no prior immunity and which could be produced rapidly in sufficient quantities. There is therefore an urgent need to investigate novel vaccination approaches. Using a combination of genomic and traditional tools, this study compares the protective efficacy in macaques of an intrarespiratory live influenza virus vaccine produced by truncating NS1 in the human influenza A/Texas/36/91 (H1N1) virus with that of a conventional vaccine based on formalin-killed whole virus. After homologous challenge, animals in the live-vaccine group had greatly reduced viral replication and pathology in lungs and reduced upper respiratory inflammation. They also had lesser induction of innate immune pathways in lungs and of interferon-sensitive genes in bronchial epithelium. This postchallenge response contrasted with that shortly after vaccination, when more expression of interferon-sensitive genes was observed in bronchial cells from the live-vaccine group. This suggested induction of a strong innate immune response shortly after vaccination with the NS1-truncated virus, followed by greater maturity of the postchallenge immune response, as demonstrated with robust influenza virus-specific CD4+ T-cell proliferation, immunoglobulin G production, and transcriptional induction of T- and B-cell pathways in lung tissue. In conclusion, a single respiratory tract inoculation with an NS1-truncated influenza virus was effective in protecting nonhuman primates from homologous challenge. This protection was achieved in the absence of significant or long-lasting adverse effects and through induction of a robust adaptive immune response.
Baskin
C R
CR
Department of Comparative Medicine, University of Washington, Seattle, Washington 981951,USA. carole.baskin@asu.edu
Bielefeldt-Ohmann
H
H
García-Sastre
A
A
Tumpey
T M
TM
Van Hoeven
N
N
Carter
V S
VS
Thomas
M J
MJ
Proll
S
S
Solórzano
A
A
Billharz
R
R
Fornek
J L
JL
Thomas
S
S
Chen
C-H
CH
Clark
E A
EA
Murali-Krishna
Kaja
K
Katze
M G
MG
D000818:Animals; D001706:Biopsy; D001769:Blood / Q000821:virology; D001980:Bronchi / Q000473:pathology / Q000821:virology; D015496:CD4-Positive T-Lymphocytes / Q000378:metabolism; D004848:Epithelium / Q000821:virology; D005260:Female; D015967:Gene Expression Regulation, Viral; D007107:Immune System / Q000821:virology*; D053118:Influenza A Virus, H1N1 Subtype / Q000378:metabolism; D008251:Macaca; D008297:Male; D009975:Orthomyxoviridae / Q000235:genetics* / Q000378:metabolism*; D014158:Transcription, Genetic; D017361:Viral Nonstructural Proteins / Q000737:chemistry* / Q000502:physiology
C085820:INS1 protein, influenza virus; D017361:Viral Nonstructural Proteins
J Virol. 2004 Dec;78(23):13037-45
15542655
N Engl J Med. 2007 Feb 15;356(7):729-31
17301305
J Gen Virol. 2005 Jan;86(Pt 1):185-95
15604446
Appl Microbiol Biotechnol. 2005 May;67(3):299-305
15660212
Vet Pathol. 2005 May;42(3):391-6
15872392
J Virol. 2005 Jun;79(12):7535-43
15919908
J Virol. 2005 Jul;79(13):8431-9
15956587
Science. 2005 Aug 12;309(5737):996
16099954
J Gen Virol. 2005 Oct;86(Pt 10):2817-21
16186237
J Exp Med. 2005 Nov 21;202(10):1433-42
16301748
Vaccine. 2006 Feb 20;24(8):1180-90
16194586
J Immunol. 2006 Apr 1;176(7):4343-51
16547272
Proc Natl Acad Sci U S A. 2006 May 2;103(18):7100-5
16627618
Lancet. 2006 May 20;367(9523):1657-64
16714186
Virology. 2006 May 25;349(1):13-21
16466763
J Virol. 2006 Jul;80(13):6295-304
16775317
J Am Assoc Lab Anim Sci. 2006 Jul;45(4):44-8
16884179
Nat Rev Microbiol. 2006 Aug;4(8):565-6
16888876
Lancet. 2006 Sep 16;368(9540):965-6
16980092
Lancet. 2006 Sep 16;368(9540):991-7
16980114
J Infect Dis. 2006 Oct 15;194(8):1032-9
16991077
Nature. 2006 Oct 5;443(7111):578-81
17006449
J Virol. 2006 Nov;80(21):10813-28
16928763
Proc Natl Acad Sci U S A. 2006 Oct 24;103(43):15987-91
17043214
Biochem J. 2005 Jan 1;385(Pt 1):85-93
15320871
Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4309-14
10725408
J Virol. 2000 Sep;74(17):7989-96
10933707
Mol Cell Biol. 2000 Sep;20(17):6259-68
10938102
J Virol. 2000 Dec;74(24):11566-73
11090154
Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2746-51
11226311
Immunity. 2001 Apr;14(4):461-70
11336691
J Virol. 2001 Jul;75(14):6687-91
11413336
Curr Opin Immunol. 2002 Aug;14(4):432-6
12088676
Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10736-41
12149435
Int Rev Immunol. 2002 Jul-Oct;21(4-5):305-37
12486817
Virology. 2003 May 10;309(2):181-9
12758165
Avian Dis. 2003;47(3 Suppl):931-3
14575089
Scand J Immunol. 2004 Jan;59(1):1-15
14723616
Am J Pathol. 2004 Mar;164(3):1021-30
14982855
Cytogenet Genome Res. 2004;105(1):11-7
15218252
J Virol. 2004 Oct;78(19):10420-32
15367608
Clin Immunol Immunopathol. 1991 Aug;60(2):153-70
1649026
J Gen Virol. 1997 Apr;78 ( Pt 4):757-65
9129647
J Infect Dis. 1997 Feb;175(2):352-63
9203656
N Engl J Med. 1998 May 14;338(20):1405-12
9580647
Virology. 1998 Dec 20;252(2):324-30
9878611
Nat Med. 1999 Oct;5(10):1157-63
10502819
J Virol. 2006 Nov;80(22):11009-18
16943300
Science. 2006 Nov 10;314(5801):997-1001
17038589
J Pediatr. 2006 Dec;149(6):737-8
17137882
J Virol. 2007 Jan;81(2):514-24
17079289
Nature. 2007 Jan 18;445(7125):319-23
17230189